No retraction, correction or concern found when last checked on Oct 17, 2026.

PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors

Amit G Deshwar, Shankar Vembu, Christina K Yung and 3 more

Genome Biology · 2015 · CC BY

Abstract

Electronic supplementary material. The online version of this article (doi:10.1186/s13059-015-0602-8) contains supplementary material, which is available to authorized users.

Full text

Its licence does not allow us to show the full text. Read it at PubMed Central:

References 49

1.
Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194:23-8.
Not in our library10.1126/science.959840
2.
Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New Engl J Med. 2012;366:883-92.
Not in our library10.1056/nejmoa1113205
3.
Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing. · 2014
Not checked
4.
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.
Not in our library10.1016/s0092-8674(00)81683-9
5.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-74.
Not in our library10.1016/j.cell.2011.02.013
6.
Aparicio S, Caldas C. The implications of clonal genome evolution for cancer medicine. New Engl J Med. 2013;368:842-51.
Not in our library10.1056/nejmra1204892
7.
Bedard PL, Hansen AR, Ratain MJ, Siu LL. Tumour heterogeneity in the clinic. Nature. 2013;501:355-64.
Not in our library10.1038/nature12627
8.
Mullighan CG, Phillips LA, Su X, Ma J, Miller CB, Shurtleff SA, et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science. 2008;322:1377-80.
Not in our library10.1126/science.1164266
9.
Navin NE, Hicks J. Tracing the tumor lineage. Mol Oncol. 2010;4:267-83.
Not in our library10.1016/j.molonc.2010.04.010
10.
Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochimica et Biophysica Acta. 2010;1805:105-17.
Not in our library10.1016/j.bbcan.2009.11.002
11.
Schuh A, Becq J, Humphray S, Alexa A, Burns A, Clifford R, et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood. 2012;120:4191-6.
Not in our library10.1182/blood-2012-05-433540
12.
Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486:617-56.
Not in our library10.1038/nature10933
13.
Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30:413-21.
Not in our library10.1038/nbt.2203
14.
Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell. 2013;152:714-26.
Not in our library10.1016/j.cell.2013.01.019
15.
THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data · 2013
No notice
16.
Strino F, Parisi F, Micsinai M, Kluger Y. TrAp: a tree approach for fingerprinting subclonal tumor composition. Nucleic Acids Res. 2013;41:e165.
Not in our library10.1093/nar/gkt641
17.
Inferring clonal evolution of tumors from single nucleotide somatic mutations · 2014
No notice
18.
Roth A, Khattra J, Yap D, Wan A, Laks E, Biele J, et al. PyClone: statistical inference of clonal population structure in cancer. Nat Methods. 2014;11:396-98.
Not in our library10.1038/nmeth.2883
19.
EXPANDS: expanding ploidy and allele frequency on nested subpopulations · 2013
No notice
20.
Chen M, Gunel M, Zhao H. SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing data. PloS One. 2013;8:e78143.
Not in our library10.1371/journal.pone.0078143
21.
Larson NB, Fridley BL. PurBayes: estimating tumor cellularity and subclonality in next-generation sequencing data. Bioinformatics. 2013;29:1888-9.
Not in our library10.1093/bioinformatics/btt293
22.
Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, Ellrott K, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45:1113-20.
Not in our library10.1038/ng.2764
23.
Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012;481:506-10.
Not in our library10.1038/nature10738
24.
Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30:413-21.
Not in our library10.1038/nbt.2203
25.
Gusnanto A, Wood HM, Pawitan Y, Rabbitts P, Berri S. Correcting for cancer genome size and tumour cell content enables better estimation of copy number alterations from next-generation sequence data. Bioinformatics. 2012;28:40-7.
Not in our library10.1093/bioinformatics/btr593
26.
The Life History of 21 Breast Cancers · 2012
Corrected
27.
Fischer A, Vázquez-García I, Illingworth CJ, Mustonen V. High-definition reconstruction of clonal composition in cancer. Cell Reports. 2014;7:1740-52.
Not in our library10.1016/j.celrep.2014.04.055
28.
PhyloWGS. https://github.com/morrislab/phylowgs.
Not in our library
29.
Behjati S, Huch M, van Boxtel R, Karthaus W, Wedge DC, Tamuri AU, et al. Genome sequencing of normal cells reveals developmental lineages and mutational processes. Nature. 2014;513:422-5.
Not in our library10.1038/nature13448
30.
Burrell RA, McGranahan N, Bartek J, Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013;501:338-45.
Not in our library10.1038/nature12625
31.
Klein CA. Selection and adaptation during metastatic cancer progression. Nature. 2013;501:365-72.
Not in our library10.1038/nature12628
32.
SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution · 2014
No notice
33.
Hajirasouliha I, Mahmoody A, Raphael BJ. A combinatorial approach for analyzing intra-tumor heterogeneity from high-throughput sequencing data. Bioinformatics. 2014;30:78-86.
Not in our library10.1093/bioinformatics/btu284
34.
Kimura M. The number of heterozygous nucleotide sites maintained in a finite population due to steady flux of mutations. Genetics. 1969;61:893.
Not in our library10.1093/genetics/61.4.893
35.
Hudson RR. Properties of a neutral allele model with intragenic recombination. Theor Popul Biol. 1983;23:183-201.
Not in our library10.1016/0040-5809(83)90013-8
36.
Zare H, Wang J, Hu A, Weber K, Smith J, Nickerson D, et al. Inferring clonal composition from multiple sections of a breast cancer. PLoS Comput Biol. 2014;10:e1003703.
Not in our library10.1371/journal.pcbi.1003703
37.
Xi R, Hadjipanayis AG, Luquette LJ, Kim TM, Lee E, Zhang J, et al. Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. Proc Nat Acad Sci. 2011;108:E1128-36.
Not in our library10.1073/pnas.1110574108
38.
TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data · 2014
No notice
39.
Miller JW, Harrison MT. A simple example of Dirichlet process mixture inconsistency for the number of components. In: Advances in neural information processing systems. 2013:199–206.
Not in our library
40.
Davis J, Goadrich M. The relationship between precision–recall and ROC curves. In: Proceedings of the 23rd International Conference on Machine Learning: 2006. p. 233–40.
Not in our library

All 49 references

Cited by papers we hold 22

The evolution of lung cancer and impact of subclonal selection in TRACERx · 2023
Corrected
Parsimonious Clone Tree Integration in cancer · 2022
Not checked
MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution · 2022
No notice
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer · 2022
No notice
Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers · 2021
Not checked
Co-evolution of tumor and immune cells during progression of multiple myeloma · 2021
No notice
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes · 2021
No notice
Divergent mutational processes distinguish hypoxic and normoxic tumours · 2020
Corrected
PyClone-VI: scalable inference of clonal population structures using whole genome data · 2020
No notice
Timing the initiation of multiple myeloma · 2020
No notice
Machine learning approaches to drug response prediction: challenges and recent progress · 2020
No notice
A multi-labeled tree dissimilarity measure for comparing “clonal trees” of tumor progression · 2019
Not checked
Enter the Matrix: Factorization Uncovers Knowledge from Omics · 2018
No notice
Reconstructing metastatic seeding patterns of human cancers · 2017
No notice
SiFit: inferring tumor trees from single-cell sequencing data under finite-sites models · 2017
No notice
Resistance to checkpoint blockade therapy through inactivation of antigen presentation · 2017
No notice
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories · 2017
No notice
Tree inference for single-cell data · 2016
No notice
MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data · 2016
No notice
Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma · 2016
No notice

and 2 more

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.